Latest Global Expansion News

Zoono Group has signed a five-year exclusive contract with Multisteps Pty Limited to apply its antimicrobial technology to fresh produce packaging in Australia, aiming to reduce food waste and boost sustainability.

ECS Botanics has successfully raised nearly A$2 million through a placement aimed at accelerating its international expansion and product development. The move underscores growing investor confidence in the medicinal cannabis company’s strategic growth plans.

RocketBoots Limited has renewed its pivotal contract with a major Australian retailer, extending an eight-year partnership and securing upfront cash payments. The company also anticipates additional inflows from banking sector pilots and R&D tax incentives, underpinning its growth trajectory.

Eden Innovations has successfully raised $4.35 million through a placement of shortfall securities, marking a key step in its financial reconstruction and global expansion plans.

Ionic Rare Earths has signed a landmark MOU with US Strategic Metals to develop rare earth magnet recycling in Missouri, advancing the US-Australia critical minerals partnership and aiming to reduce reliance on Chinese supply.

Tungsten Mining has secured a listing on the US OTCQB exchange and launched a Denver office, marking a strategic push into North America’s critical minerals market.

Neuren Pharmaceuticals reported a milestone quarter with DAYBUE net sales reaching US$101.1 million, driving a 24% jump in royalty income. The expanding patient base and community physician uptake signal strong growth ahead.

Dr Andrew Blattman, who has led IPH Limited through nearly a decade of transformative growth and international expansion, will retire as CEO in the second half of 2026. The Board has initiated a search for his successor to ensure a smooth leadership transition.

Orthocell has appointed a second Canadian distributor for its nerve repair device Remplir™, achieving full national coverage and setting the stage for initial sales this quarter.

Vmoto Limited reported a 15.9% increase in unit sales for 3Q25 alongside operational cash flow positivity and progress on new manufacturing sites in China and Thailand. The company’s expanding e-mobility solutions and strong international order book signal a promising outlook.

Orthocell has completed its first Remplir™ surgical case in Hong Kong, marking a pivotal step in its Asian commercialisation strategy. The launch at the Hong Kong Orthopaedic Association Congress and partnership with MontsMed set the stage for broader regional growth.

Activeport Group has formed a strategic partnership with Clarity Global to integrate advanced OSS/BSS software into its network orchestration platform, aiming to accelerate automation and revenue growth in the booming $60 billion telecom software sector.